Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer

Clinical trial NCT00286091 · COMPLETED

Trial details

NCT number: NCT00286091
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Refractory Prostate Cancer

Start date: 2006-01-24
Primary completion: 2010-07-30
Enrollment: 1435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.